Saeid Safaee, MD - Medicare Pulmonary Disease in Glendale, CA

Saeid Safaee, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Glendale, California. He graduated from medical school in 1987 and has 37 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Southern California Pulmonary And Critical Care Associates, Inc., Vista Critical Care Associates Inc and his current practice location is 1511 W Glenoaks Blvd, Glendale, California. You can reach out to his office (for appointments etc.) via phone at (818) 637-2200.

Saeid Safaee is licensed to practice in California (license number C-53279) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1437112604.

Contact Information

Saeid Safaee, MD
1511 W Glenoaks Blvd,
Glendale, CA 91201-1912
(818) 637-2200
(818) 637-2250



Physician's Profile

Full NameSaeid Safaee
GenderMale
SpecialityPulmonary Disease
Experience37 Years
Location1511 W Glenoaks Blvd, Glendale, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Saeid Safaee graduated from medical school in 1987
  NPI Data:
  • NPI Number: 1437112604
  • Provider Enumeration Date: 04/10/2006
  • Last Update Date: 09/24/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 4789618927
  • Enrollment ID: I20081219000079

Medical Identifiers

Medical identifiers for Saeid Safaee such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1437112604NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RP1001XInternal Medicine - Pulmonary Disease C-53279 (California)Primary
207R00000XInternal Medicine C-53279 (California)Secondary
207RC0200XInternal Medicine - Critical Care Medicine C-53279 (California)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Glendale Adventist Medical CenterGlendale, CAHospital
Glendale Mem Hospital & Hlth CenterGlendale, CAHospital
Usc Verdugo Hills HospitalGlendale, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Southern California Pulmonary And Critical Care Associates, Inc.20625602873
Vista Critical Care Associates Inc872947922510

News Archive

Researchers study about abnormal gene functioning in mitochondria

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

Lung-volume reduction surgery is a good option for many patients with end-stage emphysema

Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Saeid Safaee allows following entities to bill medicare on his behalf.
Entity NameFaculty Physicians And Surgeons Of Llusm
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205009917
PECOS PAC ID: 1153227814
Enrollment ID: O20031211000981

News Archive

Researchers study about abnormal gene functioning in mitochondria

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

Lung-volume reduction surgery is a good option for many patients with end-stage emphysema

Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

Read more Medical News

› Verified 6 days ago

Entity NameSouthern California Pulmonary & Critical Care Associates, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1831330513
PECOS PAC ID: 2062560287
Enrollment ID: O20090428000255

News Archive

Researchers study about abnormal gene functioning in mitochondria

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

Lung-volume reduction surgery is a good option for many patients with end-stage emphysema

Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

Read more Medical News

› Verified 6 days ago

Entity NamePulse Urgent Care Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1528400496
PECOS PAC ID: 4082842364
Enrollment ID: O20140113000835

News Archive

Researchers study about abnormal gene functioning in mitochondria

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

Lung-volume reduction surgery is a good option for many patients with end-stage emphysema

Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

Read more Medical News

› Verified 6 days ago

Entity NameFaculty Physicians And Surgeons Of Llusm
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1508255175
PECOS PAC ID: 1153227814
Enrollment ID: O20160216002196

News Archive

Researchers study about abnormal gene functioning in mitochondria

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

Lung-volume reduction surgery is a good option for many patients with end-stage emphysema

Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

Read more Medical News

› Verified 6 days ago

Entity NameWillow Brook Critical Care Medical Group, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811520224
PECOS PAC ID: 3476975319
Enrollment ID: O20200622002378

News Archive

Researchers study about abnormal gene functioning in mitochondria

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

Lung-volume reduction surgery is a good option for many patients with end-stage emphysema

Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

Read more Medical News

› Verified 6 days ago

Entity NameVista Critical Care Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942971189
PECOS PAC ID: 8729479225
Enrollment ID: O20211216001656

News Archive

Researchers study about abnormal gene functioning in mitochondria

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

Lung-volume reduction surgery is a good option for many patients with end-stage emphysema

Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Saeid Safaee is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Saeid Safaee, MD
1511 W Glenoaks Blvd,
Glendale, CA 91201-1912

Ph: (818) 637-2200
Saeid Safaee, MD
1511 W Glenoaks Blvd,
Glendale, CA 91201-1912

Ph: (818) 637-2200

News Archive

Researchers study about abnormal gene functioning in mitochondria

Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

Lung-volume reduction surgery is a good option for many patients with end-stage emphysema

Tens of thousands of Americans living with emphysema would benefit from a surgical procedure that removes part of the lung, according to national research presented by a Saint Louis University cardiothoracic surgeon.

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Glendale, CA

Tigran Khachatryan,
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 660 W Broadway, Glendale, CA 91204
Phone: 818-243-9600    
Dr. Jean-pierre E Antaki, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 801 S Chevy Chase Dr, #105, Glendale, CA 91205
Phone: 818-242-5299    Fax: 818-637-7607
Dr. Ellie Bloomfield, M.D.
Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: 1808 Verdugo Blvd, Suite 403, Glendale, CA 91208
Phone: 818-790-7098    Fax: 818-790-7099
Edgar H Aleman, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 435 Arden Ave, 410, Glendale, CA 91203
Phone: 818-242-4191    Fax: 818-242-4811
Michael Eugene Klein, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1818 Verdugo Blvd, #300, Glendale, CA 91208
Phone: 818-952-5332    Fax: 818-790-6830
Alen Mirzaian, M.D.
Pulmonary Disease
Medicare: May Accept Medicare Assignments
Practice Location: 1818 Verdugo Blvd Ste 401, Glendale, CA 91208
Phone: 818-790-1145    
Dr. Thomas Yarger Pocock, MD
Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: 1809 Verdugo Blvd, #200, Glendale, CA 91208
Phone: 818-790-6700    Fax: 818-790-2816

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.